@UKKidney Association Guideline: SGLT2 inhibition in Adults with Kidney Disease 2023 UPDATE in BMC Nephrol. Hard work+++ from @AndrewFrankel1 @ajroddick and the dedicated working group. Useful patient info leaflets part of outputs. https://t.co/xz1u5ZKJ4i
Access to care to maintain good mental health is critical for people with long term conditions . @Kidney_Research we are campaigning to support improvements in provision and to #LevelUp this essential healthcare for people living with kidney disease .
Reflecting on a wonderful #ABCDUKKA meeting today with excellent colleagues from @ABCDiab@UKKidney. An excellent turnout, great speakers and lively discussion.
Check out our position papers and guidelines - free to access - and share widely 👍🏽
https://t.co/cidtC2q1Ir
Next is STOP ACE trial from @sunilb1966 et al in @NEJM
Outcome eGFR at 3 years - similar in two groups.
Discontinuation group had signal of higher use of RRT or ESKD.
#ERA23
6️⃣